Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKesson
Mallinckrodt
Express Scripts
Moodys

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Details for Biologics License Application: 125559

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for BLA: 125559
Tradename:PRALUENT
Applicant:Sanofi Aventis
Ingredient:alirocumab
Patents:12
Approval Date:Apr 24, 2017
Suppliers: see list2
Pharmacology for BLA: 125559
Ingredient-typeAntibodies, Monoclonal
Drug ClassPCSK9 Inhibitor
Mechanism of ActionPCSK9 Inhibitors

US Patents for BLA: 125559

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Sanofi Aventis PRALUENT alirocumab INJECTABLE;INJECTION 125559 001 2017-04-24   Start Trial CONCIEVALVE, LLC (Minneapolis, MN) 2032-10-22 RX search
Sanofi Aventis PRALUENT alirocumab INJECTABLE;INJECTION 125559 001 2017-04-24   Start Trial 2037-07-03 RX search
Sanofi Aventis PRALUENT alirocumab INJECTABLE;INJECTION 125559 001 2017-04-24   Start Trial REGENERON PHARMACEUTICALS, INC. (Tarrytown, NY) 2035-10-12 RX search
Sanofi Aventis PRALUENT alirocumab INJECTABLE;INJECTION 125559 001 2017-04-24   Start Trial CardioForecast Ltd. (London, GB) 2037-01-12 RX search
Sanofi Aventis PRALUENT alirocumab INJECTABLE;INJECTION 125559 001 2017-04-24   Start Trial THERASYN SENSORS, INC. (Eggertsville, NY) 2033-03-14 RX search
Sanofi Aventis PRALUENT alirocumab INJECTABLE;INJECTION 125559 001 2017-04-24   Start Trial Pfizer Inc. (New York, NY) 2034-09-23 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Colorcon
Johnson and Johnson
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.